Back
Verrica Pharmaceuticals Vs. scPharmaceuticals Industry Stock Comparison
Sell
22
VRCA
Verrica Pharmaceuticals
Last Price:
1.81
Seasonality Move:
-10.89%
Sell
24
SCPH
scPharmaceuticals
Last Price:
5.20
Seasonality Move:
-14.35%
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $1.81. The Score for VRCA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
scPharmaceuticals (SCPH)
is a Sell
Is scPharmaceuticals a Buy, Sell or Hold?
- The current scPharmaceuticals [SCPH] share price is $5.18. The Score for SCPH is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- SCPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $1.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
SCPH Stock Price Chart
What is scPharmaceuticals's stock price today?
-
The scPharmaceuticals share price today is $5.18
The current trend is moderately bullish and SCPH is experiencing slight selling pressure.
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 25.08 | Sell |
Chaikin Money Flow: | -423096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.88 - 2.66) | Sell |
Bollinger Bands (100): | (3.65 - 8.75) | Sell |
SCPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 51.39 | Buy |
Chaikin Money Flow: | -114136 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.03 - 5.37) | Sell |
Bollinger Bands (100): | (4.1 - 5.08) | Buy |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.89 | Sell |
20-day SMA: | 2.12 | Sell |
50-day SMA: | 4.32 | Sell |
200-day SMA: | 5.97 | Sell |
8-day EMA: | 1.91 | Sell |
20-day EMA: | 2.33 | Sell |
50-day EMA: | 3.8 | Sell |
200-day EMA: | 5.49 | Sell |
SCPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.35 | Sell |
20-day SMA: | 5.2 | Sell |
50-day SMA: | 4.94 | Buy |
200-day SMA: | 5.04 | Buy |
8-day EMA: | 5.3 | Sell |
20-day EMA: | 5.2 | Sell |
50-day EMA: | 4.97 | Buy |
200-day EMA: | 5.18 | Sell |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.68 per share.
scPharmaceuticals Earnings Growth & SCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.13 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
Verrica Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
scPharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |